News Chart PHAXIAM Therapeutics S.A. Euronext Paris

Equities

PHXM

FR0011471135

Real-time Euronext Paris Other stock markets 08:22:37 15/05/2024 pm IST			5-day change	1st Jan Change
3.03 ^EUR	+0.17%		+4.48%	-34.13%

15/04	Phaxiam initiates trial in infective endocarditis	CF
15/04	PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	CI

2ff4bbb7f9dbb492.bw51oN0TXHzzrG-EDsLmaujhMJwthPu7jtiAcd0tMz0.LWQ70r5dGi-sxQXgaPqoH76tVtlJy6n_2r7zNYRsbG4Afx3161EaNqnUHA~30a87ffc364d8c06fb529423f3a6ee8f